Illumina Body Map 2: averaged replicates
Gene Symbol | Gene ID | Gene Info |
---|---|---|
PLAGL1
|
ENSG00000118495.14 | PLAG1 like zinc finger 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
PLAGL1 | hg19_v2_chr6_-_144329531_144329546 | 0.67 | 2.5e-05 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr14_-_106114739 | 5.66 |
ENST00000460164.1
|
RP11-731F5.2
|
RP11-731F5.2 |
chr11_-_64511789 | 5.56 |
ENST00000419843.1
ENST00000394430.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr22_+_45898712 | 5.47 |
ENST00000455233.1
ENST00000348697.2 ENST00000402984.3 ENST00000262722.7 ENST00000327858.6 ENST00000442170.2 ENST00000340923.5 ENST00000439835.1 |
FBLN1
|
fibulin 1 |
chr21_+_47518011 | 5.20 |
ENST00000300527.4
ENST00000357838.4 ENST00000310645.5 |
COL6A2
|
collagen, type VI, alpha 2 |
chr16_+_28943260 | 4.99 |
ENST00000538922.1
ENST00000324662.3 ENST00000567541.1 |
CD19
|
CD19 molecule |
chr14_-_106237742 | 4.79 |
ENST00000390551.2
|
IGHG3
|
immunoglobulin heavy constant gamma 3 (G3m marker) |
chr22_+_19744226 | 4.61 |
ENST00000332710.4
ENST00000329705.7 ENST00000359500.3 |
TBX1
|
T-box 1 |
chr16_+_1306060 | 4.49 |
ENST00000397534.2
|
TPSD1
|
tryptase delta 1 |
chr5_-_168727786 | 4.46 |
ENST00000332966.8
|
SLIT3
|
slit homolog 3 (Drosophila) |
chr5_-_168727713 | 4.36 |
ENST00000404867.3
|
SLIT3
|
slit homolog 3 (Drosophila) |
chr14_-_106209368 | 4.21 |
ENST00000390548.2
ENST00000390549.2 ENST00000390542.2 |
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker) |
chr15_-_79103757 | 4.14 |
ENST00000388820.4
|
ADAMTS7
|
ADAM metallopeptidase with thrombospondin type 1 motif, 7 |
chr16_+_226658 | 4.09 |
ENST00000320868.5
ENST00000397797.1 |
HBA1
|
hemoglobin, alpha 1 |
chrX_+_118892545 | 4.07 |
ENST00000343905.3
|
SOWAHD
|
sosondowah ankyrin repeat domain family member D |
chr14_+_102027688 | 4.06 |
ENST00000510508.4
ENST00000359323.3 |
DIO3
|
deiodinase, iodothyronine, type III |
chrX_-_153881842 | 3.92 |
ENST00000369585.3
ENST00000247306.4 |
CTAG2
|
cancer/testis antigen 2 |
chr14_-_106312010 | 3.85 |
ENST00000390556.2
|
IGHD
|
immunoglobulin heavy constant delta |
chr7_-_100171270 | 3.83 |
ENST00000538735.1
|
SAP25
|
Sin3A-associated protein, 25kDa |
chr9_+_130478345 | 3.74 |
ENST00000373289.3
ENST00000393748.4 |
TTC16
|
tetratricopeptide repeat domain 16 |
chr14_-_106111127 | 3.62 |
ENST00000390545.2
|
IGHG2
|
immunoglobulin heavy constant gamma 2 (G2m marker) |
chr14_-_106331652 | 3.62 |
ENST00000390565.1
|
IGHJ1
|
immunoglobulin heavy joining 1 |
chr12_-_48213568 | 3.56 |
ENST00000080059.7
ENST00000354334.3 ENST00000430670.1 ENST00000552960.1 ENST00000440293.1 |
HDAC7
|
histone deacetylase 7 |
chr13_+_110959598 | 3.53 |
ENST00000360467.5
|
COL4A2
|
collagen, type IV, alpha 2 |
chr22_+_23264766 | 3.52 |
ENST00000390331.2
|
IGLC7
|
immunoglobulin lambda constant 7 |
chr12_+_50355647 | 3.51 |
ENST00000293599.6
|
AQP5
|
aquaporin 5 |
chr16_+_1290694 | 3.48 |
ENST00000338844.3
|
TPSAB1
|
tryptase alpha/beta 1 |
chr12_+_52445191 | 3.45 |
ENST00000243050.1
ENST00000394825.1 ENST00000550763.1 ENST00000394824.2 ENST00000548232.1 ENST00000562373.1 |
NR4A1
|
nuclear receptor subfamily 4, group A, member 1 |
chr1_+_16084428 | 3.45 |
ENST00000510929.1
ENST00000502638.1 |
FBLIM1
|
filamin binding LIM protein 1 |
chr3_-_158450475 | 3.36 |
ENST00000237696.5
|
RARRES1
|
retinoic acid receptor responder (tazarotene induced) 1 |
chr7_-_19157248 | 3.33 |
ENST00000242261.5
|
TWIST1
|
twist family bHLH transcription factor 1 |
chr7_+_44143925 | 3.23 |
ENST00000223357.3
|
AEBP1
|
AE binding protein 1 |
chr14_-_106478603 | 3.22 |
ENST00000390596.2
|
IGHV4-4
|
immunoglobulin heavy variable 4-4 |
chr16_-_49890016 | 3.19 |
ENST00000563137.2
|
ZNF423
|
zinc finger protein 423 |
chr1_+_2160134 | 3.16 |
ENST00000378536.4
|
SKI
|
v-ski avian sarcoma viral oncogene homolog |
chr16_+_1291240 | 3.15 |
ENST00000561736.1
|
TPSAB1
|
tryptase alpha/beta 1 |
chr7_-_27169801 | 3.10 |
ENST00000511914.1
|
HOXA4
|
homeobox A4 |
chr15_+_101420028 | 3.06 |
ENST00000557963.1
ENST00000346623.6 |
ALDH1A3
|
aldehyde dehydrogenase 1 family, member A3 |
chr14_-_106092403 | 3.05 |
ENST00000390543.2
|
IGHG4
|
immunoglobulin heavy constant gamma 4 (G4m marker) |
chr8_+_99956662 | 3.05 |
ENST00000523368.1
ENST00000297565.4 ENST00000435298.2 |
OSR2
|
odd-skipped related transciption factor 2 |
chr20_+_42295745 | 3.03 |
ENST00000396863.4
ENST00000217026.4 |
MYBL2
|
v-myb avian myeloblastosis viral oncogene homolog-like 2 |
chr14_-_106758101 | 3.02 |
ENST00000390611.2
|
IGHV2-26
|
immunoglobulin heavy variable 2-26 |
chr10_-_125651258 | 3.01 |
ENST00000241305.3
|
CPXM2
|
carboxypeptidase X (M14 family), member 2 |
chr16_+_1290725 | 3.00 |
ENST00000461509.2
|
TPSAB1
|
tryptase alpha/beta 1 |
chr8_+_99956759 | 2.99 |
ENST00000522510.1
ENST00000457907.2 |
OSR2
|
odd-skipped related transciption factor 2 |
chr11_-_64512273 | 2.97 |
ENST00000377497.3
ENST00000377487.1 ENST00000430645.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr1_-_17307173 | 2.95 |
ENST00000438542.1
ENST00000375535.3 |
MFAP2
|
microfibrillar-associated protein 2 |
chr5_+_149546334 | 2.94 |
ENST00000231656.8
|
CDX1
|
caudal type homeobox 1 |
chr22_+_22453093 | 2.93 |
ENST00000390283.2
|
IGLV8-61
|
immunoglobulin lambda variable 8-61 |
chr11_+_46402744 | 2.90 |
ENST00000533952.1
|
MDK
|
midkine (neurite growth-promoting factor 2) |
chr3_-_71834318 | 2.90 |
ENST00000353065.3
|
PROK2
|
prokineticin 2 |
chr3_-_158450231 | 2.89 |
ENST00000479756.1
|
RARRES1
|
retinoic acid receptor responder (tazarotene induced) 1 |
chr1_-_1293904 | 2.86 |
ENST00000309212.6
ENST00000342753.4 ENST00000445648.2 |
MXRA8
|
matrix-remodelling associated 8 |
chr11_+_66624527 | 2.83 |
ENST00000393952.3
|
LRFN4
|
leucine rich repeat and fibronectin type III domain containing 4 |
chr1_+_1109272 | 2.82 |
ENST00000379290.1
ENST00000379289.1 |
TTLL10
|
tubulin tyrosine ligase-like family, member 10 |
chr20_+_2795626 | 2.82 |
ENST00000603872.1
ENST00000380589.4 |
C20orf141
|
chromosome 20 open reading frame 141 |
chr19_+_49838653 | 2.81 |
ENST00000598095.1
ENST00000426897.2 ENST00000323906.4 ENST00000535669.2 ENST00000597602.1 ENST00000595660.1 |
CD37
|
CD37 molecule |
chr8_-_57359131 | 2.81 |
ENST00000518974.1
ENST00000523051.1 ENST00000518770.1 ENST00000451791.2 |
PENK
|
proenkephalin |
chr15_+_81071684 | 2.80 |
ENST00000220244.3
ENST00000394685.3 ENST00000356249.5 |
KIAA1199
|
KIAA1199 |
chr21_+_47518695 | 2.79 |
ENST00000436769.1
|
COL6A2
|
collagen, type VI, alpha 2 |
chr22_+_22385332 | 2.75 |
ENST00000390282.2
|
IGLV4-69
|
immunoglobulin lambda variable 4-69 |
chr3_-_185542817 | 2.74 |
ENST00000382199.2
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr3_-_185542761 | 2.73 |
ENST00000457616.2
ENST00000346192.3 |
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr15_+_74833518 | 2.73 |
ENST00000346246.5
|
ARID3B
|
AT rich interactive domain 3B (BRIGHT-like) |
chr19_+_55888186 | 2.70 |
ENST00000291934.3
|
TMEM190
|
transmembrane protein 190 |
chr16_+_811073 | 2.66 |
ENST00000382862.3
ENST00000563651.1 |
MSLN
|
mesothelin |
chr9_-_127269661 | 2.66 |
ENST00000373588.4
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1 |
chr5_-_168728103 | 2.64 |
ENST00000519560.1
|
SLIT3
|
slit homolog 3 (Drosophila) |
chr6_+_168841817 | 2.64 |
ENST00000356284.2
ENST00000354536.5 |
SMOC2
|
SPARC related modular calcium binding 2 |
chr22_+_24115000 | 2.53 |
ENST00000215743.3
|
MMP11
|
matrix metallopeptidase 11 (stromelysin 3) |
chr17_-_6735012 | 2.53 |
ENST00000535086.1
|
TEKT1
|
tektin 1 |
chr1_-_1141927 | 2.50 |
ENST00000328596.6
ENST00000379265.5 |
TNFRSF18
|
tumor necrosis factor receptor superfamily, member 18 |
chr16_+_2880157 | 2.49 |
ENST00000382280.3
|
ZG16B
|
zymogen granule protein 16B |
chr2_+_239756671 | 2.49 |
ENST00000448943.2
|
TWIST2
|
twist family bHLH transcription factor 2 |
chr22_+_23237555 | 2.49 |
ENST00000390321.2
|
IGLC1
|
immunoglobulin lambda constant 1 (Mcg marker) |
chr14_-_106322288 | 2.48 |
ENST00000390559.2
|
IGHM
|
immunoglobulin heavy constant mu |
chr14_-_91884115 | 2.47 |
ENST00000389857.6
|
CCDC88C
|
coiled-coil domain containing 88C |
chr17_+_77751931 | 2.46 |
ENST00000310942.4
ENST00000269399.5 |
CBX2
|
chromobox homolog 2 |
chr5_+_1008910 | 2.46 |
ENST00000296849.5
ENST00000274150.4 ENST00000537972.1 |
NKD2
|
naked cuticle homolog 2 (Drosophila) |
chr14_-_75078725 | 2.45 |
ENST00000556690.1
|
LTBP2
|
latent transforming growth factor beta binding protein 2 |
chr17_-_6735035 | 2.44 |
ENST00000338694.2
|
TEKT1
|
tektin 1 |
chr14_-_75079026 | 2.41 |
ENST00000261978.4
|
LTBP2
|
latent transforming growth factor beta binding protein 2 |
chr22_+_23248512 | 2.41 |
ENST00000390325.2
|
IGLC3
|
immunoglobulin lambda constant 3 (Kern-Oz+ marker) |
chr21_-_36262032 | 2.41 |
ENST00000325074.5
ENST00000399237.2 |
RUNX1
|
runt-related transcription factor 1 |
chr8_+_37654693 | 2.39 |
ENST00000412232.2
|
GPR124
|
G protein-coupled receptor 124 |
chr15_-_89438742 | 2.39 |
ENST00000562281.1
ENST00000562889.1 ENST00000359595.3 |
HAPLN3
|
hyaluronan and proteoglycan link protein 3 |
chr20_+_2795609 | 2.39 |
ENST00000554164.1
ENST00000380593.4 |
TMEM239
TMEM239
|
transmembrane protein 239 CDNA FLJ26142 fis, clone TST04526; Transmembrane protein 239; Uncharacterized protein |
chr15_-_65360276 | 2.36 |
ENST00000421977.3
|
RASL12
|
RAS-like, family 12 |
chrX_+_153813407 | 2.36 |
ENST00000443287.2
ENST00000333128.3 |
CTAG1A
|
cancer/testis antigen 1A |
chr2_-_1748214 | 2.34 |
ENST00000433670.1
ENST00000425171.1 ENST00000252804.4 |
PXDN
|
peroxidasin homolog (Drosophila) |
chr2_+_42275153 | 2.34 |
ENST00000294964.5
|
PKDCC
|
protein kinase domain containing, cytoplasmic |
chr14_-_107035208 | 2.33 |
ENST00000390626.2
|
IGHV5-51
|
immunoglobulin heavy variable 5-51 |
chr14_-_106330824 | 2.32 |
ENST00000463911.1
|
IGHJ3
|
immunoglobulin heavy joining 3 |
chr14_-_106331447 | 2.32 |
ENST00000390564.2
|
IGHJ2
|
immunoglobulin heavy joining 2 |
chr14_-_106174960 | 2.31 |
ENST00000390547.2
|
IGHA1
|
immunoglobulin heavy constant alpha 1 |
chr16_+_2880369 | 2.30 |
ENST00000572863.1
|
ZG16B
|
zymogen granule protein 16B |
chr14_-_96180435 | 2.30 |
ENST00000556450.1
ENST00000555202.1 ENST00000554012.1 ENST00000402399.1 |
TCL1A
|
T-cell leukemia/lymphoma 1A |
chr22_+_23114284 | 2.29 |
ENST00000390313.2
|
IGLV3-12
|
immunoglobulin lambda variable 3-12 |
chr11_-_6341724 | 2.27 |
ENST00000530979.1
|
PRKCDBP
|
protein kinase C, delta binding protein |
chr16_+_71392616 | 2.27 |
ENST00000349553.5
ENST00000302628.4 ENST00000562305.1 |
CALB2
|
calbindin 2 |
chrX_+_153170455 | 2.26 |
ENST00000430697.1
ENST00000337474.5 ENST00000370049.1 |
AVPR2
|
arginine vasopressin receptor 2 |
chr12_-_48213735 | 2.26 |
ENST00000417902.1
ENST00000417107.1 |
HDAC7
|
histone deacetylase 7 |
chr16_+_1306093 | 2.25 |
ENST00000211076.3
|
TPSD1
|
tryptase delta 1 |
chr22_+_22764088 | 2.23 |
ENST00000390299.2
|
IGLV1-40
|
immunoglobulin lambda variable 1-40 |
chr22_+_23134974 | 2.23 |
ENST00000390314.2
|
IGLV2-11
|
immunoglobulin lambda variable 2-11 |
chr19_-_51071302 | 2.21 |
ENST00000389201.3
ENST00000600381.1 |
LRRC4B
|
leucine rich repeat containing 4B |
chr11_+_46402297 | 2.21 |
ENST00000405308.2
|
MDK
|
midkine (neurite growth-promoting factor 2) |
chr22_-_42322795 | 2.20 |
ENST00000291232.3
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C |
chr17_-_80291818 | 2.19 |
ENST00000269389.3
ENST00000581691.1 |
SECTM1
|
secreted and transmembrane 1 |
chr1_-_25256368 | 2.19 |
ENST00000308873.6
|
RUNX3
|
runt-related transcription factor 3 |
chr1_+_19970657 | 2.18 |
ENST00000375136.3
|
NBL1
|
neuroblastoma 1, DAN family BMP antagonist |
chr1_+_16085244 | 2.18 |
ENST00000400773.1
|
FBLIM1
|
filamin binding LIM protein 1 |
chr14_-_105635090 | 2.16 |
ENST00000331782.3
ENST00000347004.2 |
JAG2
|
jagged 2 |
chr16_+_222846 | 2.16 |
ENST00000251595.6
ENST00000397806.1 |
HBA2
|
hemoglobin, alpha 2 |
chr11_+_842808 | 2.16 |
ENST00000397397.2
ENST00000397411.2 ENST00000397396.1 |
TSPAN4
|
tetraspanin 4 |
chr19_+_45251804 | 2.16 |
ENST00000164227.5
|
BCL3
|
B-cell CLL/lymphoma 3 |
chr11_+_1891380 | 2.15 |
ENST00000429923.1
ENST00000418975.1 ENST00000406638.2 |
LSP1
|
lymphocyte-specific protein 1 |
chr1_-_1142067 | 2.14 |
ENST00000379268.2
|
TNFRSF18
|
tumor necrosis factor receptor superfamily, member 18 |
chr19_-_18902106 | 2.14 |
ENST00000542601.2
ENST00000425807.1 ENST00000222271.2 |
COMP
|
cartilage oligomeric matrix protein |
chr14_-_107211459 | 2.13 |
ENST00000390636.2
|
IGHV3-73
|
immunoglobulin heavy variable 3-73 |
chr14_-_91884150 | 2.13 |
ENST00000553403.1
|
CCDC88C
|
coiled-coil domain containing 88C |
chr7_-_150675372 | 2.12 |
ENST00000262186.5
|
KCNH2
|
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
chr15_-_65360450 | 2.12 |
ENST00000220062.4
|
RASL12
|
RAS-like, family 12 |
chr10_+_104155450 | 2.11 |
ENST00000471698.1
ENST00000189444.6 |
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) |
chr2_-_25142708 | 2.11 |
ENST00000260600.5
ENST00000435135.1 |
ADCY3
|
adenylate cyclase 3 |
chr18_+_77160282 | 2.11 |
ENST00000318065.5
ENST00000545796.1 ENST00000592223.1 ENST00000329101.4 ENST00000586434.1 |
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
chr1_+_1567474 | 2.10 |
ENST00000356026.5
|
MMP23B
|
matrix metallopeptidase 23B |
chr3_-_27763803 | 2.10 |
ENST00000449599.1
|
EOMES
|
eomesodermin |
chr1_+_1115056 | 2.10 |
ENST00000379288.3
|
TTLL10
|
tubulin tyrosine ligase-like family, member 10 |
chr19_-_7766991 | 2.09 |
ENST00000597921.1
ENST00000346664.5 |
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23) |
chr10_-_131762105 | 2.09 |
ENST00000368648.3
ENST00000355311.5 |
EBF3
|
early B-cell factor 3 |
chr17_-_41738931 | 2.08 |
ENST00000329168.3
ENST00000549132.1 |
MEOX1
|
mesenchyme homeobox 1 |
chr2_+_176981307 | 2.08 |
ENST00000249501.4
|
HOXD10
|
homeobox D10 |
chr4_+_3768075 | 2.07 |
ENST00000509482.1
ENST00000330055.5 |
ADRA2C
|
adrenoceptor alpha 2C |
chr19_+_8943074 | 2.07 |
ENST00000595891.1
|
MBD3L1
|
methyl-CpG binding domain protein 3-like 1 |
chr3_+_13610216 | 2.07 |
ENST00000492059.1
|
FBLN2
|
fibulin 2 |
chr22_+_23243156 | 2.07 |
ENST00000390323.2
|
IGLC2
|
immunoglobulin lambda constant 2 (Kern-Oz- marker) |
chr22_+_23229960 | 2.06 |
ENST00000526893.1
ENST00000532223.2 ENST00000531372.1 |
IGLL5
|
immunoglobulin lambda-like polypeptide 5 |
chr7_+_72742178 | 2.06 |
ENST00000442793.1
ENST00000413573.2 ENST00000252037.4 |
FKBP6
|
FK506 binding protein 6, 36kDa |
chr19_+_41107249 | 2.05 |
ENST00000396819.3
|
LTBP4
|
latent transforming growth factor beta binding protein 4 |
chr17_-_3819751 | 2.05 |
ENST00000225538.3
|
P2RX1
|
purinergic receptor P2X, ligand-gated ion channel, 1 |
chr10_+_112836779 | 2.05 |
ENST00000280155.2
|
ADRA2A
|
adrenoceptor alpha 2A |
chr17_+_1182948 | 2.05 |
ENST00000333813.3
|
TUSC5
|
tumor suppressor candidate 5 |
chr5_-_180018540 | 2.05 |
ENST00000292641.3
|
SCGB3A1
|
secretoglobin, family 3A, member 1 |
chr6_+_130686856 | 2.04 |
ENST00000296978.3
|
TMEM200A
|
transmembrane protein 200A |
chr22_+_39853258 | 2.04 |
ENST00000341184.6
|
MGAT3
|
mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase |
chr17_-_8648105 | 2.04 |
ENST00000539522.2
ENST00000293845.3 |
CCDC42
|
coiled-coil domain containing 42 |
chr11_+_46402482 | 2.04 |
ENST00000441869.1
|
MDK
|
midkine (neurite growth-promoting factor 2) |
chr19_+_16254488 | 2.02 |
ENST00000588246.1
ENST00000593031.1 |
HSH2D
|
hematopoietic SH2 domain containing |
chrX_-_17878827 | 2.02 |
ENST00000360011.1
|
RAI2
|
retinoic acid induced 2 |
chr2_+_121493717 | 2.02 |
ENST00000418323.1
|
GLI2
|
GLI family zinc finger 2 |
chr22_-_20792089 | 2.01 |
ENST00000405555.3
ENST00000266214.5 |
SCARF2
|
scavenger receptor class F, member 2 |
chr20_+_30458431 | 2.00 |
ENST00000375938.4
ENST00000535842.1 ENST00000310998.4 ENST00000375921.2 |
TTLL9
|
tubulin tyrosine ligase-like family, member 9 |
chr20_+_43343886 | 2.00 |
ENST00000190983.4
|
WISP2
|
WNT1 inducible signaling pathway protein 2 |
chr20_-_43438912 | 1.98 |
ENST00000541604.2
ENST00000372851.3 |
RIMS4
|
regulating synaptic membrane exocytosis 4 |
chr3_-_71834207 | 1.98 |
ENST00000295619.3
|
PROK2
|
prokineticin 2 |
chr13_-_110959478 | 1.98 |
ENST00000543140.1
ENST00000375820.4 |
COL4A1
|
collagen, type IV, alpha 1 |
chr2_+_177053307 | 1.95 |
ENST00000331462.4
|
HOXD1
|
homeobox D1 |
chr19_+_1026566 | 1.95 |
ENST00000348419.3
ENST00000565096.2 ENST00000562958.2 ENST00000562075.2 ENST00000607102.1 |
CNN2
|
calponin 2 |
chr1_+_16085263 | 1.94 |
ENST00000483633.2
ENST00000502739.1 ENST00000431771.2 |
FBLIM1
|
filamin binding LIM protein 1 |
chr22_+_22676808 | 1.94 |
ENST00000390290.2
|
IGLV1-51
|
immunoglobulin lambda variable 1-51 |
chr3_-_128207349 | 1.94 |
ENST00000487848.1
|
GATA2
|
GATA binding protein 2 |
chr19_+_16435625 | 1.94 |
ENST00000248071.5
ENST00000592003.1 |
KLF2
|
Kruppel-like factor 2 |
chr2_-_89442621 | 1.91 |
ENST00000492167.1
|
IGKV3-20
|
immunoglobulin kappa variable 3-20 |
chr19_+_11651942 | 1.91 |
ENST00000587087.1
|
CNN1
|
calponin 1, basic, smooth muscle |
chr19_-_42927251 | 1.90 |
ENST00000597001.1
|
LIPE
|
lipase, hormone-sensitive |
chr20_+_35201993 | 1.90 |
ENST00000373872.4
|
TGIF2
|
TGFB-induced factor homeobox 2 |
chr19_+_751122 | 1.90 |
ENST00000215582.6
|
MISP
|
mitotic spindle positioning |
chr7_+_331201 | 1.90 |
ENST00000510017.1
|
WI2-2373I1.2
|
WI2-2373I1.2 |
chr17_+_59529743 | 1.89 |
ENST00000589003.1
ENST00000393853.4 |
TBX4
|
T-box 4 |
chr19_+_859654 | 1.89 |
ENST00000592860.1
|
CFD
|
complement factor D (adipsin) |
chr11_-_68780824 | 1.89 |
ENST00000441623.1
ENST00000309099.6 |
MRGPRF
|
MAS-related GPR, member F |
chr1_-_32801825 | 1.88 |
ENST00000329421.7
|
MARCKSL1
|
MARCKS-like 1 |
chr9_+_139863695 | 1.88 |
ENST00000371629.1
|
C9orf141
|
chromosome 9 open reading frame 141 |
chr11_-_45928830 | 1.88 |
ENST00000449465.1
|
C11orf94
|
chromosome 11 open reading frame 94 |
chr10_+_88728189 | 1.88 |
ENST00000416348.1
|
ADIRF
|
adipogenesis regulatory factor |
chr17_-_73839792 | 1.88 |
ENST00000590762.1
|
UNC13D
|
unc-13 homolog D (C. elegans) |
chr14_-_106878083 | 1.88 |
ENST00000390619.2
|
IGHV4-39
|
immunoglobulin heavy variable 4-39 |
chr20_-_3662666 | 1.88 |
ENST00000350009.2
|
ADAM33
|
ADAM metallopeptidase domain 33 |
chr1_-_17304771 | 1.87 |
ENST00000375534.3
|
MFAP2
|
microfibrillar-associated protein 2 |
chrX_-_101771645 | 1.87 |
ENST00000289373.4
|
TMSB15A
|
thymosin beta 15a |
chr19_-_1652575 | 1.86 |
ENST00000587235.1
ENST00000262965.5 |
TCF3
|
transcription factor 3 |
chr20_-_3662866 | 1.86 |
ENST00000356518.2
ENST00000379861.4 |
ADAM33
|
ADAM metallopeptidase domain 33 |
chr12_+_58005204 | 1.86 |
ENST00000286494.4
|
ARHGEF25
|
Rho guanine nucleotide exchange factor (GEF) 25 |
chr20_+_43343517 | 1.86 |
ENST00000372865.4
|
WISP2
|
WNT1 inducible signaling pathway protein 2 |
chr16_+_2867228 | 1.86 |
ENST00000005995.3
ENST00000574813.1 |
PRSS21
|
protease, serine, 21 (testisin) |
chr16_+_66638616 | 1.85 |
ENST00000564060.1
ENST00000565922.1 |
CMTM3
|
CKLF-like MARVEL transmembrane domain containing 3 |
chr11_+_46402583 | 1.85 |
ENST00000359803.3
|
MDK
|
midkine (neurite growth-promoting factor 2) |
chr2_+_219745020 | 1.84 |
ENST00000258411.3
|
WNT10A
|
wingless-type MMTV integration site family, member 10A |
chr5_+_131593364 | 1.84 |
ENST00000253754.3
ENST00000379018.3 |
PDLIM4
|
PDZ and LIM domain 4 |
chr18_+_77155942 | 1.84 |
ENST00000397790.2
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
chr22_+_23063100 | 1.84 |
ENST00000390309.2
|
IGLV3-19
|
immunoglobulin lambda variable 3-19 |
chr1_+_1567546 | 1.83 |
ENST00000378675.3
|
MMP23B
|
matrix metallopeptidase 23B |
chr12_+_54393880 | 1.83 |
ENST00000303450.4
|
HOXC9
|
homeobox C9 |
chr7_-_38370536 | 1.82 |
ENST00000390343.2
|
TRGV8
|
T cell receptor gamma variable 8 |
chr19_+_33210645 | 1.82 |
ENST00000444215.2
|
TDRD12
|
tudor domain containing 12 |
chr9_-_129885010 | 1.82 |
ENST00000373425.3
|
ANGPTL2
|
angiopoietin-like 2 |
chr16_-_15149917 | 1.82 |
ENST00000287706.3
|
NTAN1
|
N-terminal asparagine amidase |
chr16_-_89268070 | 1.81 |
ENST00000562855.2
|
SLC22A31
|
solute carrier family 22, member 31 |
chr14_-_106781017 | 1.81 |
ENST00000390612.2
|
IGHV4-28
|
immunoglobulin heavy variable 4-28 |
chr1_-_159869912 | 1.81 |
ENST00000368099.4
|
CCDC19
|
coiled-coil domain containing 19 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 6.3 | GO:1902811 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
2.0 | 12.3 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
2.0 | 12.1 | GO:0030421 | defecation(GO:0030421) |
1.4 | 4.3 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
1.4 | 2.8 | GO:2000309 | positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) |
1.4 | 5.5 | GO:0002432 | granuloma formation(GO:0002432) |
1.4 | 4.1 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
1.3 | 4.0 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
1.3 | 2.5 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
1.2 | 1.2 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
1.2 | 6.1 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
1.2 | 4.6 | GO:0035854 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
1.1 | 4.4 | GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
1.1 | 3.3 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
1.0 | 3.1 | GO:0003192 | mitral valve formation(GO:0003192) |
1.0 | 4.1 | GO:0060032 | notochord regression(GO:0060032) |
1.0 | 7.1 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
1.0 | 3.0 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
1.0 | 2.9 | GO:1904897 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
1.0 | 4.8 | GO:0007538 | primary sex determination(GO:0007538) |
1.0 | 2.9 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
0.9 | 3.7 | GO:0060166 | olfactory pit development(GO:0060166) |
0.9 | 2.8 | GO:1903465 | vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
0.9 | 1.8 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.9 | 3.5 | GO:0060901 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
0.9 | 3.5 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.9 | 4.3 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.8 | 2.5 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.8 | 2.5 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
0.8 | 3.3 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.8 | 67.6 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.8 | 3.1 | GO:0044691 | tooth eruption(GO:0044691) |
0.8 | 8.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.8 | 3.1 | GO:0018963 | phthalate metabolic process(GO:0018963) |
0.8 | 0.8 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.8 | 0.8 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
0.7 | 2.2 | GO:0070376 | regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
0.7 | 2.9 | GO:1903803 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.7 | 2.2 | GO:0072011 | glomerular endothelium development(GO:0072011) |
0.7 | 5.7 | GO:0043585 | nose morphogenesis(GO:0043585) |
0.7 | 2.1 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.7 | 3.6 | GO:0044855 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.7 | 3.5 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.7 | 2.1 | GO:0046730 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
0.7 | 0.7 | GO:0071456 | cellular response to hypoxia(GO:0071456) |
0.7 | 3.5 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.7 | 2.8 | GO:0009956 | radial pattern formation(GO:0009956) |
0.7 | 3.5 | GO:0051866 | general adaptation syndrome(GO:0051866) |
0.7 | 2.7 | GO:0072299 | posterior mesonephric tubule development(GO:0072166) negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
0.7 | 2.7 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.7 | 2.0 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.7 | 0.7 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.7 | 3.3 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.6 | 1.9 | GO:0060981 | cell migration involved in coronary angiogenesis(GO:0060981) |
0.6 | 5.7 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.6 | 0.6 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.6 | 0.6 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.6 | 3.7 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.6 | 1.9 | GO:2000657 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
0.6 | 0.6 | GO:0002663 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
0.6 | 3.7 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.6 | 0.6 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
0.6 | 1.8 | GO:2000349 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of CD40 signaling pathway(GO:2000349) |
0.6 | 0.6 | GO:0072554 | blood vessel lumenization(GO:0072554) |
0.6 | 1.8 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.6 | 1.8 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.6 | 1.8 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
0.6 | 5.9 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.6 | 1.8 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.6 | 2.9 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.6 | 0.6 | GO:0048754 | branching morphogenesis of an epithelial tube(GO:0048754) |
0.6 | 0.6 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.6 | 1.7 | GO:0050720 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) interleukin-1 beta biosynthetic process(GO:0050720) |
0.6 | 0.6 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.6 | 1.7 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.6 | 1.7 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.6 | 1.7 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
0.6 | 2.8 | GO:0032796 | uropod organization(GO:0032796) |
0.6 | 11.7 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.6 | 1.7 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
0.6 | 1.7 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.6 | 15.5 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.6 | 1.7 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
0.6 | 1.7 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.6 | 1.7 | GO:0071848 | regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
0.6 | 2.2 | GO:0018277 | protein deamination(GO:0018277) |
0.5 | 3.3 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.5 | 1.6 | GO:0060489 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
0.5 | 1.1 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
0.5 | 1.6 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.5 | 2.7 | GO:0038156 | interleukin-5-mediated signaling pathway(GO:0038043) interleukin-3-mediated signaling pathway(GO:0038156) |
0.5 | 2.7 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.5 | 8.7 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.5 | 5.4 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.5 | 0.5 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.5 | 2.2 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.5 | 3.7 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.5 | 1.6 | GO:0007493 | endodermal cell fate determination(GO:0007493) |
0.5 | 1.6 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.5 | 1.6 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.5 | 2.1 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) |
0.5 | 2.1 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
0.5 | 2.6 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.5 | 1.0 | GO:0048371 | lateral mesodermal cell differentiation(GO:0048371) |
0.5 | 4.7 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.5 | 1.5 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.5 | 1.5 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.5 | 1.0 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.5 | 0.5 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.5 | 4.0 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.5 | 4.0 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.5 | 6.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.5 | 1.9 | GO:0071663 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
0.5 | 2.9 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.5 | 0.5 | GO:0070613 | regulation of protein processing(GO:0070613) |
0.5 | 1.9 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.5 | 1.4 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.5 | 2.8 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
0.5 | 4.5 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.5 | 0.9 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.5 | 1.8 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.5 | 2.7 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.4 | 1.8 | GO:0072223 | metanephric glomerular mesangium development(GO:0072223) |
0.4 | 2.2 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.4 | 1.3 | GO:0038001 | paracrine signaling(GO:0038001) |
0.4 | 0.9 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.4 | 1.3 | GO:0090274 | regulation of somatostatin secretion(GO:0090273) positive regulation of somatostatin secretion(GO:0090274) |
0.4 | 2.6 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.4 | 1.3 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
0.4 | 1.3 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.4 | 1.3 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.4 | 1.3 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.4 | 7.8 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.4 | 3.9 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.4 | 1.3 | GO:1990868 | response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
0.4 | 0.8 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
0.4 | 1.3 | GO:0071373 | cellular response to luteinizing hormone stimulus(GO:0071373) |
0.4 | 5.0 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.4 | 1.7 | GO:0006272 | leading strand elongation(GO:0006272) |
0.4 | 3.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.4 | 2.1 | GO:0061056 | sclerotome development(GO:0061056) |
0.4 | 1.7 | GO:0060374 | mast cell differentiation(GO:0060374) |
0.4 | 4.6 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.4 | 2.5 | GO:0032826 | natural killer cell differentiation involved in immune response(GO:0002325) regulation of natural killer cell differentiation involved in immune response(GO:0032826) |
0.4 | 4.5 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.4 | 0.4 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
0.4 | 0.8 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.4 | 0.8 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
0.4 | 2.4 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.4 | 5.7 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.4 | 1.6 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
0.4 | 1.6 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.4 | 0.8 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.4 | 1.2 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
0.4 | 2.0 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.4 | 0.4 | GO:0060022 | hard palate development(GO:0060022) |
0.4 | 0.8 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.4 | 0.8 | GO:0046222 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
0.4 | 2.0 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.4 | 2.4 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.4 | 0.4 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.4 | 1.2 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.4 | 1.6 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.4 | 2.3 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.4 | 7.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.4 | 0.4 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
0.4 | 1.2 | GO:1904604 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
0.4 | 0.8 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.4 | 1.1 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
0.4 | 1.1 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) |
0.4 | 4.9 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.4 | 0.7 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.4 | 10.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.4 | 1.5 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.4 | 1.1 | GO:0072143 | mesangial cell development(GO:0072143) |
0.4 | 4.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.4 | 1.1 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.4 | 1.1 | GO:0002372 | myeloid dendritic cell cytokine production(GO:0002372) |
0.4 | 1.5 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.4 | 1.8 | GO:1903597 | negative regulation of gap junction assembly(GO:1903597) |
0.4 | 1.8 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.4 | 1.8 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
0.4 | 1.5 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.4 | 1.5 | GO:2001303 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
0.4 | 0.7 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
0.4 | 2.2 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.4 | 1.8 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.4 | 2.9 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.4 | 0.4 | GO:0072034 | renal vesicle induction(GO:0072034) |
0.4 | 2.5 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.4 | 1.1 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.4 | 2.1 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
0.4 | 2.1 | GO:0061042 | vascular wound healing(GO:0061042) |
0.4 | 1.8 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.4 | 1.8 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.4 | 0.4 | GO:0097018 | renal albumin absorption(GO:0097018) regulation of renal albumin absorption(GO:2000532) |
0.4 | 2.5 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.4 | 0.4 | GO:0045401 | positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) |
0.3 | 1.0 | GO:0007351 | blastoderm segmentation(GO:0007350) tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.3 | 0.3 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.3 | 1.0 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.3 | 3.4 | GO:1990834 | response to odorant(GO:1990834) |
0.3 | 0.7 | GO:1904938 | dopaminergic neuron axon guidance(GO:0036514) chemorepulsion of dopaminergic neuron axon(GO:0036518) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.3 | 1.7 | GO:0015862 | uridine transport(GO:0015862) |
0.3 | 2.0 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.3 | 1.7 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.3 | 2.4 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.3 | 0.3 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.3 | 0.7 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
0.3 | 3.3 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.3 | 0.7 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.3 | 1.0 | GO:0072720 | response to dithiothreitol(GO:0072720) |
0.3 | 0.7 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
0.3 | 0.6 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.3 | 1.0 | GO:0060381 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
0.3 | 1.3 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.3 | 2.2 | GO:0001878 | response to yeast(GO:0001878) |
0.3 | 1.0 | GO:0002818 | intracellular defense response(GO:0002818) |
0.3 | 1.0 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.3 | 2.5 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
0.3 | 1.9 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.3 | 0.9 | GO:0060829 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
0.3 | 0.3 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.3 | 0.9 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.3 | 0.3 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.3 | 2.5 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.3 | 0.9 | GO:1902203 | negative regulation of hepatocyte growth factor receptor signaling pathway(GO:1902203) regulation of cellular response to hepatocyte growth factor stimulus(GO:2001112) negative regulation of cellular response to hepatocyte growth factor stimulus(GO:2001113) |
0.3 | 0.9 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.3 | 0.6 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
0.3 | 0.9 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.3 | 0.3 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.3 | 0.9 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.3 | 2.5 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.3 | 1.8 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.3 | 1.2 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.3 | 0.3 | GO:0003245 | growth involved in heart morphogenesis(GO:0003241) cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
0.3 | 2.1 | GO:0035799 | ureter maturation(GO:0035799) |
0.3 | 7.6 | GO:0015671 | gas transport(GO:0015669) oxygen transport(GO:0015671) |
0.3 | 0.9 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.3 | 0.6 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.3 | 1.5 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.3 | 0.9 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.3 | 0.3 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.3 | 0.9 | GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.3 | 3.0 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
0.3 | 0.3 | GO:0097535 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
0.3 | 1.8 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.3 | 2.7 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.3 | 5.9 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.3 | 0.9 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.3 | 1.5 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.3 | 0.3 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.3 | 0.6 | GO:0097264 | self proteolysis(GO:0097264) |
0.3 | 1.5 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.3 | 3.5 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.3 | 2.6 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.3 | 0.9 | GO:0035508 | positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
0.3 | 1.4 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.3 | 3.4 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.3 | 0.9 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
0.3 | 3.4 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
0.3 | 0.3 | GO:0001555 | oocyte growth(GO:0001555) |
0.3 | 0.9 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.3 | 0.6 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.3 | 0.8 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.3 | 2.0 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.3 | 0.6 | GO:0014009 | glial cell proliferation(GO:0014009) |
0.3 | 0.6 | GO:0042092 | type 2 immune response(GO:0042092) |
0.3 | 1.7 | GO:2000669 | negative regulation of dendritic cell apoptotic process(GO:2000669) |
0.3 | 5.6 | GO:0001946 | lymphangiogenesis(GO:0001946) |
0.3 | 0.8 | GO:1904772 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
0.3 | 0.8 | GO:0033037 | polysaccharide localization(GO:0033037) |
0.3 | 1.9 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.3 | 1.4 | GO:0032218 | riboflavin transport(GO:0032218) |
0.3 | 0.8 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.3 | 0.8 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.3 | 1.1 | GO:0022009 | establishment of endothelial blood-brain barrier(GO:0014045) central nervous system vasculogenesis(GO:0022009) |
0.3 | 0.8 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
0.3 | 0.3 | GO:0021794 | thalamus development(GO:0021794) |
0.3 | 2.2 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.3 | 2.4 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.3 | 2.4 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.3 | 0.5 | GO:0061198 | fungiform papilla formation(GO:0061198) |
0.3 | 0.3 | GO:0007521 | muscle cell fate determination(GO:0007521) |
0.3 | 0.8 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.3 | 1.1 | GO:0052227 | multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
0.3 | 2.1 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.3 | 1.9 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.3 | 1.1 | GO:0060721 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.3 | 0.8 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.3 | 1.3 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.3 | 1.3 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.3 | 0.8 | GO:0035425 | autocrine signaling(GO:0035425) |
0.3 | 8.4 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.3 | 3.1 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.3 | 7.6 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.3 | 0.3 | GO:2001076 | regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
0.3 | 0.8 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
0.3 | 0.8 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.3 | 0.5 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
0.3 | 0.5 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.3 | 0.3 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.3 | 0.8 | GO:1990426 | homologous recombination-dependent replication fork processing(GO:1990426) |
0.3 | 3.6 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.3 | 1.0 | GO:1903979 | negative regulation of microglial cell activation(GO:1903979) |
0.3 | 0.5 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
0.3 | 2.0 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.3 | 2.8 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.3 | 1.5 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.3 | 2.0 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.3 | 2.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.3 | 0.8 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.3 | 2.5 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.2 | 0.5 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.2 | 0.7 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.2 | 0.7 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
0.2 | 0.5 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
0.2 | 0.7 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.2 | 0.2 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.2 | 3.2 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 1.2 | GO:0099541 | trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.2 | 0.5 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.2 | 1.5 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
0.2 | 0.2 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.2 | 1.7 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 1.0 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.2 | 2.4 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 0.7 | GO:0045554 | TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
0.2 | 1.0 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.2 | 1.0 | GO:1904799 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.2 | 1.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 0.2 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.2 | 4.5 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) |
0.2 | 1.4 | GO:0040034 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.2 | 0.2 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.2 | 3.3 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.2 | 27.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.2 | 0.5 | GO:0048102 | autophagic cell death(GO:0048102) |
0.2 | 0.7 | GO:0007369 | gastrulation(GO:0007369) |
0.2 | 5.6 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.2 | 0.5 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.2 | 1.4 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.2 | 1.2 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 1.6 | GO:0060026 | convergent extension(GO:0060026) |
0.2 | 3.0 | GO:0045141 | meiotic telomere clustering(GO:0045141) |
0.2 | 1.4 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.2 | 0.2 | GO:0033628 | regulation of cell adhesion mediated by integrin(GO:0033628) |
0.2 | 1.4 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.2 | 1.6 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.2 | 1.4 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.2 | 1.1 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.2 | 2.0 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.2 | 0.7 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.2 | 0.7 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
0.2 | 0.7 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
0.2 | 0.7 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
0.2 | 1.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 1.1 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.2 | 0.9 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.2 | 0.7 | GO:0060872 | semicircular canal development(GO:0060872) |
0.2 | 0.7 | GO:0086098 | angiotensin-activated signaling pathway involved in heart process(GO:0086098) |
0.2 | 2.9 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.2 | 0.7 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
0.2 | 1.1 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.2 | 0.2 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.2 | 2.6 | GO:0032196 | transposition(GO:0032196) |
0.2 | 0.7 | GO:1900737 | regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
0.2 | 0.7 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.2 | 0.9 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.2 | 0.9 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.2 | 1.7 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
0.2 | 4.3 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.2 | 0.7 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
0.2 | 0.2 | GO:0060324 | face development(GO:0060324) |
0.2 | 1.1 | GO:0061047 | regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.2 | 2.1 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.2 | 1.7 | GO:0042100 | B cell proliferation(GO:0042100) |
0.2 | 3.9 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.2 | 0.6 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.2 | 0.4 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.2 | 0.6 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.2 | 0.6 | GO:0080120 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
0.2 | 4.9 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 35.0 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.2 | 0.8 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.2 | 1.1 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.2 | 1.9 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.2 | 1.9 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 0.8 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.2 | 1.5 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.2 | 1.5 | GO:0051026 | chiasma assembly(GO:0051026) |
0.2 | 0.8 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.2 | 0.8 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.2 | 0.6 | GO:1902743 | regulation of lamellipodium organization(GO:1902743) |
0.2 | 0.6 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
0.2 | 2.9 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.2 | 1.9 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.2 | 1.6 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.2 | 0.8 | GO:0044026 | DNA hypermethylation(GO:0044026) hypermethylation of CpG island(GO:0044027) |
0.2 | 1.6 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.2 | 0.4 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.2 | 2.7 | GO:0007144 | female meiosis I(GO:0007144) |
0.2 | 2.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 0.6 | GO:1904617 | regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
0.2 | 0.6 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.2 | 0.8 | GO:0015870 | acetylcholine transport(GO:0015870) |
0.2 | 0.2 | GO:0033024 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.2 | 0.6 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.2 | 0.2 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.2 | 1.4 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.2 | 1.2 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
0.2 | 0.2 | GO:0071901 | negative regulation of protein serine/threonine kinase activity(GO:0071901) |
0.2 | 0.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.2 | 1.8 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 1.2 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.2 | 0.8 | GO:0051918 | regulation of fibrinolysis(GO:0051917) negative regulation of fibrinolysis(GO:0051918) |
0.2 | 2.0 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.2 | 0.6 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.2 | 0.8 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.2 | 0.4 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
0.2 | 3.6 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.2 | 0.6 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.2 | 1.8 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.2 | 0.4 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
0.2 | 1.2 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.2 | 0.6 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.2 | 1.0 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.2 | 1.4 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.2 | 0.6 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.2 | 1.9 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.2 | 1.9 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.2 | 0.8 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.2 | 1.7 | GO:0007621 | negative regulation of female receptivity(GO:0007621) regulation of female receptivity(GO:0045924) |
0.2 | 2.3 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.2 | 7.3 | GO:0071800 | podosome assembly(GO:0071800) |
0.2 | 0.4 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.2 | 2.4 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.2 | 0.4 | GO:0021592 | fourth ventricle development(GO:0021592) |
0.2 | 0.4 | GO:0045732 | positive regulation of protein catabolic process(GO:0045732) |
0.2 | 0.8 | GO:1903377 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.2 | 0.4 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) chromosome movement towards spindle pole(GO:0051305) |
0.2 | 0.9 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
0.2 | 0.4 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 1.7 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 0.4 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
0.2 | 1.5 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.2 | 1.5 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 1.9 | GO:2000371 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
0.2 | 1.7 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.2 | 3.7 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.2 | 0.7 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.2 | 0.9 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.2 | 0.5 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.2 | 1.8 | GO:0033622 | integrin activation(GO:0033622) |
0.2 | 0.5 | GO:1903461 | Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
0.2 | 2.0 | GO:0042148 | strand invasion(GO:0042148) |
0.2 | 1.1 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.2 | 0.5 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.2 | 1.3 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.2 | 1.8 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.2 | 0.7 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
0.2 | 1.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.2 | 0.2 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.2 | 2.8 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.2 | 1.4 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.2 | 0.2 | GO:0031076 | embryonic camera-type eye development(GO:0031076) |
0.2 | 0.9 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.2 | 0.5 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.2 | 0.5 | GO:0035038 | female pronucleus assembly(GO:0035038) |
0.2 | 0.3 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.2 | 1.0 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 1.7 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 8.3 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.2 | 1.4 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.2 | 0.7 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.2 | 0.5 | GO:0009405 | pathogenesis(GO:0009405) |
0.2 | 0.5 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.2 | 0.2 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
0.2 | 3.2 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.2 | 1.0 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.2 | 1.5 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.2 | 5.2 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.2 | 2.7 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.2 | 0.5 | GO:0044727 | DNA demethylation of male pronucleus(GO:0044727) |
0.2 | 1.2 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
0.2 | 2.5 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.2 | 0.7 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 0.3 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
0.2 | 0.5 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.2 | 0.8 | GO:1902913 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.2 | 0.3 | GO:0032350 | regulation of hormone metabolic process(GO:0032350) regulation of thyroid hormone generation(GO:2000609) |
0.2 | 0.3 | GO:0070055 | mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
0.2 | 10.6 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.2 | 1.6 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.2 | 1.1 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.2 | 1.1 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.2 | 1.9 | GO:0032963 | collagen metabolic process(GO:0032963) multicellular organismal macromolecule metabolic process(GO:0044259) |
0.2 | 26.5 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.2 | 1.3 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.2 | 0.9 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.2 | 0.8 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.2 | 1.4 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.2 | 0.6 | GO:0030047 | actin modification(GO:0030047) |
0.2 | 2.7 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.2 | 0.3 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
0.2 | 0.5 | GO:0060629 | regulation of homologous chromosome segregation(GO:0060629) |
0.2 | 0.6 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.2 | 0.9 | GO:0061187 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.2 | 0.5 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.2 | 0.2 | GO:1902230 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.2 | 0.9 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
0.2 | 0.5 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) positive regulation of DNA biosynthetic process(GO:2000573) |
0.2 | 1.8 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) negative regulation of protein depolymerization(GO:1901880) |
0.2 | 0.8 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.2 | 0.3 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.2 | 0.8 | GO:0048749 | compound eye development(GO:0048749) |
0.2 | 3.4 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.2 | 1.5 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.2 | 1.4 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.2 | 0.9 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 0.5 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.2 | 0.5 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.2 | 0.9 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.2 | 0.8 | GO:2000567 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.1 | 0.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 5.1 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.1 | 0.6 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.1 | 0.3 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 0.7 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 0.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.6 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.1 | 0.3 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 2.8 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.1 | 0.4 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.1 | 8.5 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 0.3 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
0.1 | 1.7 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.6 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
0.1 | 1.6 | GO:0030220 | platelet formation(GO:0030220) |
0.1 | 0.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 3.0 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
0.1 | 2.6 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.4 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 1.4 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.1 | 0.4 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
0.1 | 0.9 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 0.9 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 1.0 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 1.0 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.1 | 0.7 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.1 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.3 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.1 | 0.7 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 1.6 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.1 | 0.6 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) |
0.1 | 0.3 | GO:1900239 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
0.1 | 0.4 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 3.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 1.8 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 1.2 | GO:0030238 | male sex determination(GO:0030238) |
0.1 | 1.4 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.3 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.4 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 1.9 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.1 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.1 | 3.6 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.1 | 2.2 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.5 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.4 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.1 | 0.3 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.1 | 0.4 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 5.0 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.1 | 1.4 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.5 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.1 | 1.2 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.4 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
0.1 | 0.8 | GO:1901256 | macrophage colony-stimulating factor production(GO:0036301) regulation of macrophage colony-stimulating factor production(GO:1901256) |
0.1 | 6.0 | GO:0003341 | cilium movement(GO:0003341) |
0.1 | 1.1 | GO:0045007 | depurination(GO:0045007) |
0.1 | 1.9 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.1 | 0.3 | GO:1990776 | response to angiotensin(GO:1990776) |
0.1 | 0.1 | GO:1904327 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
0.1 | 1.1 | GO:0070836 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
0.1 | 1.1 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.1 | 0.7 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.8 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.1 | 2.0 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 4.9 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 1.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.9 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.7 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.1 | 0.3 |